Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparative evaluation of IV propofol + fentanyl vs ketamine + midazolam for sedation in uncooperative children undergoing dental procedures
IRCT20211123053154N1Phase 3Completed
- Sponsor
- Shahid Beheshti University of Medical Sciences
- Start
- Jan 2022
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of propofol, fentanyl, ketamine and midazolam in Dental anxiety (2 arms), sponsored by Shahid Beheshti University of Medical Sciences. Primary endpoint: Sedative effectiveness. Started Jan 2022; status: completed.
02
Drugs
propofolfentanylketaminemidazolam
03
Conditions
Dental anxiety
Beyond the preview
Go deeper on IRCT20211123053154N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20211123053154N1.